Umbilical Cord Blood Stem Cell Market Growth and Industry Progress

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Growth In Market Value Is Expected For The Stem Cell Umbilical Cord Blood Market Between 2026 And 2030?

The stem cell umbilical cord blood market size has seen rapid expansion in recent years. It is projected to grow from $7.98 billion in 2025 to $9.39 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 17.7%. The market’s historical growth can be linked to factors such as the increased adoption of stem cell transplants, the proliferation of public cord blood banks, significant advancements in hematological treatments, a rising understanding of stem cell therapies, and enhancements in neonatal healthcare infrastructure.

The stem cell umbilical cord blood market is projected for significant expansion in the coming years. It is anticipated to reach $17.83 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 17.4%. This growth during the forecast period is driven by several factors, including the escalating demand for personalized regenerative treatments, increased investments in cell therapy research, the broadening scope of treatments for neurological and immune disorders, the rising acceptance of hybrid banking models, and innovations in stem cell expansion technologies. Key trends expected during this period involve a greater embrace of advanced cryopreservation techniques, the increasing application of stem cells in regenerative medicine, the expanding availability of private cord blood banking services, a heightened emphasis on preserving cell quality and viability, and the development of hybrid cord blood storage solutions.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24715&type=smp

What Key Factors Are Affecting The Stem Cell Umbilical Cord Blood Market Demand?

Rising childbirth rates are projected to fuel the expansion of the stem cell umbilical cord blood market in the future. Childbirth rates represent the count of live births per thousand individuals within a defined population over a typical one-year span. This increase in childbirth rates stems from the enhanced accessibility and reduced cost of fertility treatments, allowing more families to conceive. Umbilical cord blood stem cells hold significant value for infants because they possess hematopoietic stem cells, capable of addressing numerous blood, immune, and genetic conditions. These cells offer an exact genetic match for the baby and can potentially benefit siblings or other family members. As an example, the U.S. Centers for Disease Control and Prevention, a federal agency based in the U.S., reported in April 2025 that birth numbers in the USA rose from 3,596,017 in 2023 to 3,622,673 in 2024, indicating a 1% increase. Consequently, the growing childbirth rates are propelling the expansion of the stem cell umbilical cord blood market.

How Are Different Segments Classified In The Stem Cell Umbilical Cord Blood Market Segment Analysis?

The stem cell umbilical cord blood market covered in this report is segmented –

1) By Product Type: Cord Blood Stem Cells, Cord Tissue Stem Cells

2) By Technology: Cryopreservation, Stem Cell Expansion, Cell Separation

3) By Storage Services: Public Cord Blood Banks, Private Cord Blood Banks, Hybrid Cord Blood Banks

4) By Application: Hematological Disorders, Metabolic Diseases, Immune System Disorders, Neurological Disorders, Other Applications

5) By End-User: Hospitals, Research Institutes, Biotechnology Companies, Other End-Users

Subsegments:

1) By Cord Blood Stem Cells: Hematopoietic Stem Cells, Mesenchymal Stem Cells, Endothelial Progenitor Cells, Regulatory T Cells, Natural Killer Cells, Dendritic Cells

2) By Cord Tissue Stem Cells: Mesenchymal Stem Cells, Epithelial Cells, Fibroblasts, Neural Progenitor Cells

What Trends Are Influencing Changes In The Stem Cell Umbilical Cord Blood Market?

Leading entities within the stem cell umbilical cord blood market are prioritizing the creation of novel treatments and securing necessary authorizations, with a focus on cord blood cell therapy to address rare genetic conditions, enhance immune system recovery, and support regenerative medicine applications. This specific therapy involves employing stem cells obtained from umbilical cord blood to manage a range of illnesses through the regeneration or repair of compromised blood, immune, and other bodily tissue systems. As an illustration, in October 2024, StemCyte, a US-based biotechnology firm, was granted the regenerative medicine advanced therapy designation by the U.S. Food and Drug Administration (FDA) for its hematopoietic progenitor cell cord blood therapy (HPC Cord Blood), intended for the treatment of Long COVID-19 syndrome. This particular therapeutic approach leverages stem cells from umbilical cord blood to foster healing and diminish inflammation. Furthermore, it has demonstrated promise in addressing conditions related to the immune system and degenerative diseases, providing a non-invasive, ethically procured alternative for cutting-edge regenerative medical interventions.

Who Are The Companies Driving Activity In The Stem Cell Umbilical Cord Blood Market?

Major companies operating in the stem cell umbilical cord blood market are Global Cord Blood Corporation, Vita 34 AG, Cordlife Group Limited, StemLife Berhad, MediPost Co Ltd, Smart Cells International Ltd, StemCyte Inc, Celularity Inc, Next Biosciences Pty Ltd, Esperite NV, Cryo Cell International Inc, FamiCord Group, Cells4Life Group LLP, Cryoviva Biotech Pvt Ltd, Americord Registry LLC, ViaCord LLC, China Cord Blood Corporation, CBR Systems Inc, Cord Blood Registry, LifeCell International Pvt Ltd, CryoSave India Pvt Ltd

Get The Full Stem Cell Umbilical Cord Blood Market Report:

https://www.thebusinessresearchcompany.com/report/stem-cell-umbilical-cord-blood-global-market-report

Where Is The Stem Cell Umbilical Cord Blood Market Primarily Concentrated By Region?

North America was the largest region in the stem cell umbilical cord blood market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the stem cell umbilical cord blood market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Stem Cell Umbilical Cord Blood Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/stem-cell-umbilical-cord-blood-global-market-report

Browse Through More Reports Similar to the Global Stem Cell Umbilical Cord Blood Market 2026, By The Business Research Company

Stem Cell Market Report 2026

https://www.thebusinessresearchcompany.com/report/stem-cell-global-market-report

Stem Cells Therapy Market Report

https://www.thebusinessresearchcompany.com/report/stem-cells-therapy-global-market-report

Stem Cell Assay Market Report

https://www.thebusinessresearchcompany.com/report/stem-cell-assay-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795